NCT05646680
- Conditions
- Adnexal Diseases, Adnexal Lesion, Endocrine Gland Neoplasms, +14 more
- Locations
-
- University Hospital Ghent, Belgium
Clinical trial condition
Ovarian Cancer
Explore clinical trials studying Ovarian Cancer. Study availability and eligibility vary by location and protocol.
1,442 public trials
326 recruiting studies
Ovarian Cancer trial results
NCT04089189
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Xiaohua.Wu Shanghai, China
NCT04640480
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +45 more
- Locations
-
- CHA Medical Center Seongnam-si, Gyeonggi-do, South Korea
- The Severance Hospital of the Yonsei University Seoul, South Korea
- The Catholic University of Korea Seoul ST. Mary's Hospital Seoul, South Korea
NCT05360680
- Conditions
- Adnexal Diseases, Colonic Diseases, Colorectal Cancer, +40 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Stanford Advanced Medicine Cancer Center Palo Alto, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT05041257
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
- Locations
-
- City of Hope National Medical Center /ID# 269928 Duarte, California, United States
- University of California Los Angeles /ID# 269969 Los Angeles, California, United States
- University Colorado Cancer Center /ID# 269930 Aurora, Colorado, United States
- Women'S Cancer Care /ID# 269925 Covington, Louisiana, United States
Completed
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Indications of RP903
NCT06846099
- Conditions
- Adnexal Diseases, Breast Cancer, Breast Diseases, +26 more
- Locations
-
- Beijing Cancer Hospital Beijing, China
- The First Affiliated Hospital of Bengbu Medical College Bengbu, China
- Jilin Cancer Hospital Changchun, China
- Jilin University First Hospital Changchun, China
Completed
Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers
NCT05483933
- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
- Locations
-
- University of Arkansas for Medical sciences Little Rock, Arkansas, United States
- City of Hope Duarte, California, United States
- Robert H.Lurie ComprehensiveCancer Center, Northwestern University Chicago, Illinois, United States
- START Midwest Grand Rapids, Michigan, United States
NCT02001272
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Notre-Dame Hospital of the CHUM Montreal, Canada
- Herlev Hospital Herlev, Denmark
- Kuopio University Hospital Kuopio, Finland
- Service d'Oncologie Médicale - Centre Hospitalier d'Alès Alès, France
NCT03959761
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
- Locations
-
- Hospices Civils de Lyon Lyon, France
Completed
Spectroscopy in Ovarian Cancer
NCT04817449
- Conditions
- Adnexal Diseases, Cysts, Endocrine Gland Neoplasms, +17 more
- Locations
-
- University Hospitals Bristol and Weston NHS Trust Bristol, United Kingdom